GeneralConnection.com ➔ Dictionary
Dictionary Search

hemophilia b

Synonyms

Noun

1. hemophilia B

2. haemophilia B, Christmas disease, hemophilia, haemophilia, bleeder's disease

Usage
FIX inhibitors pose hurdles for kids with hemophilia B: UK study - Hemophilia News Today
Hemophilia Treatment Market Industry Report & Forecast 2035 - Business Research Insights
FDA Expands Marstacimab Indication in Hemophilia A and B - Conexiant
Pfizer’s Hympavzi secures FDA expanded indications for haemophilia - Pharmaceutical Technology
U.S. FDA Approves Pfizer’s HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need - Business Wire
Final Analysis of a Study of Etranacogene Dezaparvovec for Hemophilia B - NEJM
Factor IX-Padua AAV gene therapy in hemophilia B: phases 1/2 and 3 trials - Nature
FDA Expands Pfizer’s Hympavzi Approval to Pediatric Hemophilia Patients and Those with Inhibitors - BioPharm International
Single-Dose Gene Therapy Shows Promising Safety, Efficacy, and Patient-Reported Outcomes in Hemophilia B - Docwire News
Integrating Gene Therapy into Clinical Care for Hemophilia B - CGTLive®
US FDA Approves Pfizer’s Hympavzi for Children with Hemophilia - Новости GxP
New treatment for Hemophilia B brings hope to patients - FOX 2 Detroit
Optimization of hemophilia B treatment via population PK modeling of rIX-FP, including a 3-week regimen - Frontiers
New data suggest gene therapy may reach more hemophilia B patients - Hemophilia News Today
4 Things to Expect for the Future of Hemophilia Treatment - Docwire News
How durable is gene therapy for haemophilia B? - Nature
China’s first hemophilia B gene therapy now approved in Macao - Hemophilia News Today
New gene therapy reduces bleeding rates for hemophilia B patients - Hemophilia News Today
Gene therapy Beqvez sustains gains in 6-year hemophilia B study - Hemophilia News Today
Utah Center for Bleeding & Clotting Disorders at University of Utah Health Administers New Gene Therapy for Hemophilia B - School of Medicine | University of Utah
Hemophilia B Gene Therapy Continues to Reduce Bleeding - Medscape
Overview of gene therapy for hemophilia: questions and answers to navigate the innovation - National Institutes of Health (.gov)
Steven W. Pipe, MD, on Integrating Gene Therapy into Clinical Care for Hemophilia B - CGTLive®
Five-year results highlight new treatment option for hemophilia B - Hemophilia News Today
The potential of bringing hemophilia B gene therapy to younger patients - CGTLive®
Pfizer's Hympavzi Wins USFDA Nod for Pediatric Hemophilia B, Broader Patient Use - Medical Dialogues
Longer Follow-Up Data Reinforce Concizumab’s Efficacy in Hemophilia A and B With Inhibitors - Docwire News
Gene therapy can help reduce joint bleeds in hemophilia B: New data - Hemophilia News Today
Marstacimab Superior to On-Demand Prophylaxis for Hemophilia A, B, With Inhibitors - Docwire News
FDA may OK Hympavzi for children 6 and older with hemophilia A or B - Hemophilia News Today
Distribution of people with hemophilia B in the U.S. in 2024, by age group - Statista
Gene therapy comes of age to staunch hemophilia B - St. Jude Children's Research Hospital
Sanofi’s hemophilia B therapy Alprolix approved for 6-month room-temperature storage - koreabiomed.com
Hemophilia Studies Today: Points of Interest - Docwire News
FDA approves expanded indication for Pfizer’s HYMPAVZI - grafa.com
Gene Therapy Supply Runs Out, Company Warns of Treatment Delays - MedPage Today
ASH: CSL proves efficacy of hemophilia B gene therapy Hemgenix holds up after 5 years - Fierce Pharma
Advances in hemophilia, sickle cell disease, and thalassemia - Penn Medicine
HOPE-B Shows Bleeding Control Still Holding at 5 Years - Docwire News
Hemophilia B gene therapy Hemgenix to be covered in Canada - Hemophilia News Today
Steven W. Pipe, MD, on the Implications of the Final Data From Hemgenix’s HOPE-B Trial - CGTLive®
New FIX versions may be used to create hemophilia B treatments - Hemophilia News Today
Karmanos Cancer Institute Becomes First and Only Free-Standing Cancer Center to Treat Hemophilia B with New Gene Therapy - McLaren Health
HOPE-B: 5-Year Etranacogene Dezaparvovec Maintains Durable Efficacy and Safety in Hemophilia B, With Steven Pipe, MD - HCPLive
AAV Gene Therapy in Severe Hemophilia B - NEJM
End-of-Study Results From Hemgenix’s HOPE-B Trial - CGTLive®
Phase 3 Analysis: Concizumab Noninferior to Prior Prophylaxis in Hemophilia A, B, Without Inhibitors - Docwire News
Steven W. Pipe, MD, on the End-of-Study Results From Hemgenix’s HOPE-B Trial - CGTLive®
Marstacimab in the treatment of patients with hemophilia A and B - Via Medica Journals
Little interest in gene therapy for many with severe hemophilia: German study - Hemophilia News Today
European Commission Approves Pfizer’s HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors - Business Wire
Exploring Eptacog Beta Dosing in Patients With Hemophilia A or B - Docwire News
First-in-human trial of hemophilia B treatment BE-101 starts dosing - Hemophilia News Today
EAHAD 2026: Nine-Year Outcomes of Gene Therapy - EMJ
CSL Canada Announces First Canadian Patient Receives HEMGENIX® (etranacogene dezaparvovec) Hemophilia B Gene Therapy in Ontario, Canada - Barchart.com
Building safeguards for gene therapy in haemophilia - The Lancet
Hemgenix (etranacogene dezaparvovec) for hemophilia - Hemophilia News Today
The Implications of the Final Data From Hemgenix’s HOPE-B Trial - CGTLive®
Gene Therapy Maintains Efficacy in Hemophilia B Out to 5 Years - MedPage Today
Speaking with the man, first in Canada, to receive breakthrough hemophilia B gene therapy - CP24
AAV gene therapy shows durable benefit in hemophilia B - 2 Minute Medicine
Phase 3 Study Evaluates Marstacimab for Hemophilia A, B, Without Inhibitors - Docwire News
Tailored collagen binding of albumin-fused hyperactive coagulation factor IX dictates in vivo distribution and functional properties - Nature
FDA expands Pfizer’s HYMPAVZI approval - Indian Pharma Post
Canadian first: One-time gene therapy given to London, Ont., hemophilia B patient - CP24
FDA approves Alhemo® as once-daily prophylactic treatment to prevent or reduce the frequency of bleeding episodes for adults and children 12 years of age and older with hemophilia A or B (HA/HB) without inhibitors - PR Newswire
CSL Behring Signs Letter of Intent with pan-Canadian Pharmaceutical Alliance (pCPA) for Public Reimbursement of HEMGENIX® (etranacogene dezaparvovec), the First Gene Therapy for Hemophilia B - Yahoo Finance
How Gene Therapy Is Transforming Hemophilia B Treatment - Docwire News
CSL Canada Announces First Canadian Patient Receives HEMGENIX® (etranacogene dezaparvovec) Hemophilia B Gene Therapy in Ontario, Canada - PR Newswire Canada
CSL says hemophilia B gene therapy is temporarily out of stock, warns of treatment delays - Endpoints News
China Explores Weight-Based Pricing for First Domestic Hemophilia B Gene Therapy - NAVLIN DAILY
First Patient Dosed in Clinical Trial of An Engineered B-Cell Medicine for Hemophilia B - Docwire News
Alhemo Indication Expanded to Include Hemophilia A/B Without Inhibitors - MPR - Medical Professionals Reference
FDA Approves Extended Indication for Concizumab-Mtci for Hemophilia A and B - Docwire News
Hemophilia B Pipeline 2026 Report Highlights Next-Gen Gene Therapies, FDA Advances, and Clinical Momentum Across Novo Nordisk, Pfizer, Sanofi & Emerging Biotechs | DelveInsight - Barchart.com
Netherlands Temporarily Includes Hympavzi in Basic Package for Hemophilia A & B - NAVLIN DAILY
Hemophilia Market Size, Share, Growth | CAGR of 6.9% - Market.us
How to Plan for Emergencies When You Have Hemophilia B - Everyday Health
Therapy now available for patients with Hemophilia B - CP24
Children's Hospital of Philadelphia played key role in developing new treatment for hemophilia - CBS News
CSL Canada Announces First Canadian Patient Receives HEMGENIX® (etranacogene dezaparvovec) Hemophilia B Gene Therapy in Ontario, Canada - marketscreener.com
FDA Grants Priority Review For Pfizer’s Marstacimab for Hemophilia A or B - PharmTech.com
Hemophilia B gene therapy benefits last more than a decade: Study - Hemophilia News Today
How Fitusiran Changes the Treatment Landscape in Hemophilia: Guy Young, MD - The American Journal of Managed Care® (AJMC®)
Hemophilia B gene therapy demonstrates long-term success - St. Jude Children's Research Hospital
Pfizer’s Hympavzi Cuts Bleeding by 93% in Hemophilia A and B Patients with Inhibitors, Phase 3 Trial Finds - Managed Healthcare Executive
Multimillion-dollar gene therapies weren’t supposed to face competition. China has other plans - Endpoints News
Extended hemophilia half-life products aid care, but raise costs - Hemophilia News Today
Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B - NEJM
Gene Therapy with Fidanacogene Elaparvovec in Adults with Hemophilia B - NEJM
First subject dosed in Be Biopharma’s trial of haemophilia B therapy - Clinical Trials Arena
Biogen Idec to Present Data from Hematology Programs, Including ELOCTATE™ and ALPROLIX® at ASH Annual Meeting - Biogen
Sustained Clinical Benefit of AAV Gene Therapy in Severe Hemophilia B - NEJM
Phase 1–2 Trial of AAVS3 Gene Therapy in Patients with Hemophilia B - NEJM
With hemophilia B, a lifetime of worry eased with one infusion - Penn Today
EVOLVING THE TREATMENT LANDSCAPE WITH THE FIRST THERAPY APPROVED FOR PEOPLE WITH HEMOPHILIA A AND B WITH OR WITHOUT INHIBITORS - The American Journal of Managed Care® (AJMC®)
Marstacimab Improved Key Bleeding Outcomes in Hemophilia A or B - The American Journal of Managed Care® (AJMC®)
CDC Hemophilia Mutation Projects (CHAMP and CHBMP) - Centers for Disease Control and Prevention | CDC (.gov)
Single-dose gene therapy is potentially life-changing for adults with hemophilia B - Penn Medicine
Gene Therapy Cuts Bleeding and Medicine for Hemophilia B Patients for Over a Decade - Managed Healthcare Executive
Foreign Language Equivalents
Foreign Language Equivalents of 'hemophilia b'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
hemohilia b,   hrmophilia b,   hemophili ab,   hhemophilia b,   hempphilia b,   hemophiila b,   jemophilia b,   hemophiliia b,   heemophilia b,   hemophiia b,   hemophillia b,   hemophiilia b,   hemophilai b,   hemophhilia b,   hemophi;ia b,   hemophiliab ,   heomphilia b,   hemopihlia b,   henophilia b,   hemo[hilia b,   hwmophilia b,   hmophilia b,   hmeophilia b,   hemopphilia b,   hemopgilia b,   hemophikia b,   hemophilia n,   hemopholia b,   hempohilia b,   hemopilia b,   hemophilia v,   hemophili b,   emophilia b,   hemoohilia b,   heophilia b,   ehmophilia b,   hemiphilia b,   hemophiliaa b,   hemophulia b,   hemmophilia b,   hemophliia b,   hemophilia bb,   hemophlia b,   hemoophilia b,   gemophilia b,   hemophilis b,   hemophilia b,   hemophiloa b,   hemophilua b,   hemohpilia b,   he,ophilia b,   hemopjilia b,   hemophilia ,   hemphilia b,   hemophila b,   hemophiliab
Words Starting with Letter - 'V'
viciously viciousness vicissitude
vicksburg vicomte de chateaubriand vicomte ferdinand marie de lesseps
victim victimisation victimise
victimised victimiser victimization
victimize victimized victimizer
victimless crime victor victor emanuel ii
victor emanuel iii victor franz hess victor herbert
victor hess victor horta victor hugo
« Go to Page 54            Go to Page 56 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z